Evidence map›Paper›PMID 30894498›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism.

Xiaofei E, Paul Meraner, Ping Lu, Jill M Perreira, Aaron M Aker, William M McDougall, Ronghua Zhuge, Gary C Chan, Rachel M Gerstein, Patrizia Caposio and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 133 citations in OpenAlex.

  1. Article
  2. Article
  3. Cellular antibody affinity-based CRISPR screening identifies JUNB as a broadly acting antiviral factor.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Xiaofei EDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605; xiaofei.e@umassmed.edu timothy.kowalik@umassmed.edu.
Paul MeranerDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
Ping LuDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
Jill M PerreiraDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
Aaron M AkerDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
William M McDougallDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
Ronghua ZhugeDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
Gary C ChanDepartment of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, NY 13210.
Rachel M GersteinDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
Patrizia CaposioVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR 97006.
Andrew D YurochkoDepartment of Microbiology and Immunology, Center for Molecular & Tumor Virology, Louisiana State University Health Sciences Center, Shreveport, LA 71106.ORCID 0000-0002-6452-5813
Abraham L BrassDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605.
Timothy F KowalikDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA 01605; xiaofei.e@umassmed.edu timothy.kowalik@umassmed.edu.
University of Massachusetts Chan Medical School · USChildren's Cancer Therapy Development Institute · USLouisiana State University Health Sciences Center Shreveport · USSUNY Upstate Medical University · US

Funding

The Administrative CoreP01AI127335 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI JAY A NELSON · 2017 to 2026
$24.6M
Analysis of HCMV Infection of Monocytes and MacrophagesR01AI056077 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI YUROCHKO, ANDREW D · 2004 to 2020
$4.7M
Acquisition of HCMV from breast milk-correlates of protectionR01AI109001 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BOPPANA, SURESH B · 2014 to 2017
$2.8M
COBRE Center for Molecular and Tumor VirologyP20GM103433 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI O'CALLAGHAN, DENNIS JOHN · 2012 to 2012
$1.9M
NIAID NIH HHS P01 AI127335NIAID NIH HHS R01 AI056077NIAID NIH HHS R01 AI109001NIGMS NIH HHS P20 GM103433
6 · The paper itself

Abstract

A human cytomegalovirus (HCMV) pentameric glycoprotein complex (PC), gH-gL-UL128-UL130-UL131A, is necessary for viral infection of clinically relevant cell types, including epithelial cells, which are important for interhost transmission and disease. We performed genome-wide CRISPR/Cas9 screens of different cell types in parallel to identify host genes specifically required for HCMV infection of epithelial cells. This effort identified a multipass membrane protein, OR14I1, as a receptor for HCMV infection. This olfactory receptor family member is required for HCMV attachment, entry, and infection of epithelial cells and is dependent on the presence of viral PC. OR14I1 is required for AKT activation and mediates endocytosis entry of HCMV. We further found that HCMV infection of epithelial cells is blocked by a synthetic OR14I1 peptide and inhibitors of adenylate cyclase and protein kinase A (PKA) signaling. Identification of OR14I1 as a PC-dependent HCMV host receptor associated with epithelial tropism and the role of the adenylate cyclase/PKA/AKT-mediated signaling pathway in HCMV infection reveal previously unappreciated targets for the development of vaccines and antiviral therapies.

Indexed as

Signal TransductionA549 CellsCyclic AMP-Dependent Protein KinasesCytomegalovirusEpithelial CellsHEK293 CellsHeLa CellsHumansMultiprotein ComplexesProto-Oncogene Proteins c-aktViral ProteinsViral TropismCyclic AMP-Dependent Protein KinasesMultiprotein ComplexesProto-Oncogene Proteins c-aktViral ProteinsCRISPR screenhuman cytomegalovirusOR14I1pentameric glycoprotein complexvirus receptor

Identifiers

PMID30894498
PMCPMC6452726
OpenAlexW2924038702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.